Literature DB >> 33156508

Waiting list mortality and the potential of donation after circulatory death heart transplantations in the Netherlands.

S Roest1, S E Kaffka Genaamd Dengler2, V van Suylen3, N P van der Kaaij2, K Damman4, L W van Laake5, J A Bekkers6, M Dalinghaus7, M E Erasmus3, O C Manintveld8.   

Abstract

BACKGROUND: With more patients qualifying for heart transplantation (HT) and fewer hearts being transplanted, it is vital to look for other options. To date, only organs from brain-dead donors have been used for HT in the Netherlands. We investigated waiting list mortality in all Dutch HT centres and the potential of donation after circulatory death (DCD) HT in the Netherlands.
METHODS: Two different cohorts were evaluated. One cohort was defined as patients who were newly listed or were already on the waiting list for HT between January 2013 and December 2017. Follow-up continued until September 2018 and waiting list mortality was calculated. A second cohort of all DCD donors in the Netherlands (lung, liver, kidney and pancreas) between January 2013 and December 2017 was used to calculate the potential of DCD HT.
RESULTS: Out of 395 patients on the waiting list for HT, 196 (50%) received transplants after a median waiting time of 2.6 years. In total, 15% died while on the waiting list before a suitable donor heart became available. We identified 1006 DCD donors. After applying exclusion criteria and an age limit of 50 years, 122 potential heart donors remained. This number increased to 220 when the age limit was extended to 57 years.
CONCLUSION: Waiting list mortality in the Netherlands is high. HT using organs from DCD donors has great potential in the Netherlands and could lead to a reduction in waiting list mortality. Cardiac screening will eventually determine the true potential.

Entities:  

Keywords:  Donation after circulatory death; Heart transplantation; Mortality; Waiting list

Year:  2020        PMID: 33156508      PMCID: PMC7843666          DOI: 10.1007/s12471-020-01505-y

Source DB:  PubMed          Journal:  Neth Heart J        ISSN: 1568-5888            Impact factor:   2.380


  20 in total

1.  Sex Differences in Mortality Based on United Network for Organ Sharing Status While Awaiting Heart Transplantation.

Authors:  Eileen M Hsich; Eugene H Blackstone; Lucy Thuita; Dennis M McNamara; Joseph G Rogers; Hemant Ishwaran; Jesse D Schold
Journal:  Circ Heart Fail       Date:  2017-06       Impact factor: 8.790

2.  The potential of heart transplantation from donation after circulatory death donors within the United Kingdom.

Authors:  Simon Messer; Aravinda Page; Sally Rushton; Marius Berman; Steven Tsui; Pedro Catarino; Stephen R Large
Journal:  J Heart Lung Transplant       Date:  2019-04-29       Impact factor: 10.247

3.  "I Need Help"-A mnemonic to aid timely referral in advanced heart failure.

Authors:  Jay Baumwol
Journal:  J Heart Lung Transplant       Date:  2017-02-10       Impact factor: 10.247

4.  Euthanasia through living organ donation: Ethical, legal, and medical challenges.

Authors:  Jan A M Bollen; David Shaw; Guido de Wert; Rankie Ten Hoopen; Dirk Ysebaert; Ernst van Heurn; Walther N K A van Mook
Journal:  J Heart Lung Transplant       Date:  2018-07-27       Impact factor: 10.247

5.  Potential suitability for transplantation of hearts from human non-heart-beating donors: data review from the Gift of Life Donor Program.

Authors:  Arun K Singhal; John D Abrams; Jun Mohara; Richard D Hasz; Howard M Nathan; Carol A Fisher; Satoshi Furukawa; Bruce I Goldman
Journal:  J Heart Lung Transplant       Date:  2005-10       Impact factor: 10.247

6.  Adult heart transplantation with distant procurement and ex-vivo preservation of donor hearts after circulatory death: a case series.

Authors:  Kumud K Dhital; Arjun Iyer; Mark Connellan; Hong C Chew; Ling Gao; Aoife Doyle; Mark Hicks; Gayathri Kumarasinghe; Claude Soto; Andrew Dinale; Bruce Cartwright; Priya Nair; Emily Granger; Paul Jansz; Andrew Jabbour; Eugene Kotlyar; Anne Keogh; Christopher Hayward; Robert Graham; Phillip Spratt; Peter Macdonald
Journal:  Lancet       Date:  2015-04-14       Impact factor: 79.321

7.  What is the potential increase in the heart graft pool by cardiac donation after circulatory death?

Authors:  Timothée Noterdaeme; Olivier Detry; Marie-France Hans; Eric Nellessen; Didier Ledoux; Jean Joris; Michel Meurisse; Jean-Olivier Defraigne
Journal:  Transpl Int       Date:  2012-10-18       Impact factor: 3.782

8.  The potential of cardiac allografts from donors after cardiac death at the University of Wisconsin Organ Procurement Organization.

Authors:  Satoru Osaki; James E Anderson; Maryl R Johnson; Niloo M Edwards; Takushi Kohmoto
Journal:  Eur J Cardiothorac Surg       Date:  2009-08-19       Impact factor: 4.191

9.  Thirty years of heart transplantation at the University Medical Centre Utrecht.

Authors:  A Sammani; A M Wind; J H Kirkels; C Klöpping; M P Buijsrogge; F Z Ramjakhan; F W Asselbergs; N de Jonge
Journal:  Neth Heart J       Date:  2017-09       Impact factor: 2.380

Review 10.  Transplantation of Hearts Donated after Circulatory Death.

Authors:  Christopher W White; Simon J Messer; Stephen R Large; Jennifer Conway; Daniel H Kim; Demetrios J Kutsogiannis; Jayan Nagendran; Darren H Freed
Journal:  Front Cardiovasc Med       Date:  2018-02-13
View more
  5 in total

1.  Atrioventricular Block Necessitating Chronic Ventricular Pacing After Tricuspid Valve Surgery in Patients With a Systemic Right Ventricle: Long-Term Follow-Up.

Authors:  Marieke Nederend; Monique R M Jongbloed; Philippine Kiès; Hubert W Vliegen; Berto J Bouma; Madelien V Regeer; Dave R Koolbergen; Mark G Hazekamp; Martin J Schalij; Anastasia D Egorova
Journal:  Front Cardiovasc Med       Date:  2022-05-10

2.  Case report of the broad spectrum of late complications in an adult patient with univentricular physiology palliated by the Fontan circulation.

Authors:  Marieke Nederend; Anastasia D Egorova; Hubert W Vliegen; Arno A W Roest; Bastian N Ruijter; Tijmen Korteweg; Maarten K Ninaber; Katja Zeppenfeld; Mark G Hazekamp; Philippine Kiès; Monique R M Jongbloed
Journal:  Eur Heart J Case Rep       Date:  2022-02-16

Review 3.  Hopes and Hurdles of Employing Mesenchymal Stromal Cells in the Treatment of Cardiac Fibrosis.

Authors:  Sebastian Neuber; Maximilian Y Emmert; Timo Z Nazari-Shafti
Journal:  Int J Mol Sci       Date:  2021-11-30       Impact factor: 5.923

4.  The first experience with sodium-glucose cotransporter 2 inhibitor for the treatment of systemic right ventricular failure.

Authors:  Anastasia D Egorova; Marieke Nederend; Laurens F Tops; Hubert W Vliegen; Monique R M Jongbloed; Philippine Kiès
Journal:  ESC Heart Fail       Date:  2022-03-30

Review 5.  Renal Delivery of Pharmacologic Agents During Machine Perfusion to Prevent Ischaemia-Reperfusion Injury: From Murine Model to Clinical Trials.

Authors:  Rossana Franzin; Alessandra Stasi; Marco Fiorentino; Simona Simone; Rainer Oberbauer; Giuseppe Castellano; Loreto Gesualdo
Journal:  Front Immunol       Date:  2021-07-06       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.